Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Addex Therapeutics Ltd. Sponsored ADR (ADXN) had Return on Equity of -39.55% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$-0.00M |
|
$-2.28M |
|
-- |
|
$-0.00M |
|
$0.96M |
|
$-0.96M |
|
$-1.30M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-2.28M |
|
$-0.96M |
|
$-0.96M |
|
0.89M |
|
0.89M |
|
$-2.35 |
|
$-2.35 |
|
| Balance Sheet Financials | |
$2.03M |
|
$0.00M |
|
$5.65M |
|
$7.68M |
|
$1.45M |
|
-- |
|
$0.48M |
|
$1.93M |
|
$5.75M |
|
$5.75M |
|
$5.75M |
|
0.98M |
|
| Cash Flow Statement Financials | |
$-2.62M |
|
$-0.82M |
|
$1.43M |
|
$4.03M |
|
$1.98M |
|
$-2.06M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.62M |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-0.04 |
|
-2263.69 |
|
|
Return on Equity |
-39.55% |
-39.55% |
|
-29.62% |
|
-39.55% |
|
$5.85 |
|
$-2.93 |
|
$-2.93 |
|